mirum制药(mirm)
Mirum制药(MIRM):
Mirum制药(MIRM) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-008791 Act: 34 Size: 12 KB 网页链接
Mirum制药(MIRM):
Mirum制药(MIRM) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193805-23-000121 Act: 34 Size: 131 KB 网页链接
Mirum制药(MIRM):
Mirum制药(MIRM) SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001580642-23-000863 Act: 34 Size: 58 KB 网页链接
Mirum制药(MIRM):
Mirum制药(MIRM) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-006715 Act: 34 Size: 15 MB 网页链接
Mirum制药(MIRM):
Mirum制药(MIRM) 8-K Current report, item 8.01 Accession Number: 0001193125-23-067794 Act: 34 Size: 154 KB 网页链接
Mirum制药(MIRM):
Mirum制药(MIRM) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001157523-23-000411 Act: 34 Size: 306 KB 网页链接
牛唐:
在Ipsen 成功并购Albireo Pharma(ALBO)之前,有三家药企在和ALBO谈收购。Mirum制药(MIRM)甘李药业(SH603087)
Mirum制药(MIRM):
Mirum制药(MIRM) SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-23-001259 Act: 34 Size: 109 KB 网页链接





